📖
NCLX Inhibition plus Ca(2+) Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma.
Zhao C, He L, Lu Y, Deng Z, Wei H, Zhang Y, Yang M, Yin T

NCLX Inhibition plus Ca(2+) Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma.

Medicine & Health Published 2026 Verification Pending

Overview & Synopsis

Open access biomedical research article published in Adv Sci (Weinh).

Indexed from repository: PubMed Central (pmc.ncbi.nlm.nih.gov)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title NCLX Inhibition plus Ca(2+) Delivery Potentiates Electroporation and Antitumor Immunity in Pancreatic Ductal Adenocarcinoma.
Author / Organization Zhao C, He L, Lu Y, Deng Z, Wei H, Zhang Y, Yang M, Yin T
Subject & Discipline Adv Sci (Weinh)
Categories Medicine & Health
Publication Year 2026
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website PubMed Central (pmc.ncbi.nlm.nih.gov)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-137300
Original Source Link Visit Source Page on pmc.ncbi.nlm.nih.gov »